跳到正文
cccskills
免费在 GitHub 公开

pediatric-obesity-etiology-screener

Screen a child with obesity for red flags suggesting monogenic, syndromic, or secondary endocrine causes — distinguishing atypical from typical exogenous obesity. Trigger when a clinician asks whether obesity could be genetic or hormonal, suspects Prader-Willi syndrome, Cushing disease, hypothyroidism, ROHHAD, Bardet-Biedl syndrome, leptin deficiency, or craniopharyngioma, or when a child has early-onset severe obesity, short stature with obesity, hyperphagia, hypotonia, dysmorphic features, or developmental delay with weight gain.

中文简介正在准备中。当前显示原文说明。

实测评分 未实测

查看安装方法

包含的文件(1)

  • SKILL.md7.7 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Pediatric Obesity: Atypical Etiology Screener

Distinguish typical exogenous obesity from monogenic, syndromic, or secondary endocrine causes using a structured red flag screen.


Step 1 — Establish the Typical Baseline

Typical exogenous obesity looks like this — if ALL present, atypical cause is less likely:

FeatureTypical Exogenous Obesity
OnsetGradual, often after age 5
HeightNormal to tall for age (advanced skeletal maturation)
DevelopmentNormal milestones
AppetiteIncreased but not insatiable
Dysmorphic featuresAbsent
Family historyUsually positive for obesity

⚠️ If any feature deviates from the above, proceed through the red flag screen below.


Step 2 — Red Flag Screen

Work through each domain. One or more flags = investigate further.


🔴 Domain 1: Age and Onset of Obesity

Red FlagSuspect
Obesity onset before age 2–5 years, especially severeMonogenic obesity: leptin deficiency, leptin receptor deficiency, POMC deficiency, MC4R mutation
Abrupt, rapid weight gain at any ageHypothalamic lesion (craniopharyngioma), ROHHAD/ROHHADNET syndrome, new-onset endocrine disorder

🔴 Domain 2: Growth Pattern

Red FlagSuspect
Short stature in a child with obesityEndocrine cause (Cushing disease, hypothyroidism, GH deficiency) or genetic syndrome
Declining height velocity despite obesityEndocrine disorder — especially Cushing or hypothyroidism

📏 Key rule: Exogenous obesity accelerates growth. A child with obesity who is short or growing slowly almost certainly has a non-exogenous cause. This is one of the most important red flags in paediatric practice.


🔴 Domain 3: Appetite

Red FlagSuspect
Marked, uncontrollable hyperphagia — insatiable hunger, food-seeking behaviour, food obsessionMonogenic obesity (leptin deficiency, POMC deficiency, MC4R), Prader-Willi syndrome, hypothalamic obesity

🔴 Domain 4: Development and Neurology

Red FlagSuspect
Developmental delay or intellectual disabilitySyndromic causes: Prader-Willi, Bardet-Biedl, Cohen syndrome
Hypotonia in infancy followed by hyperphagia and rapid weight gain in early childhoodPrader-Willi syndrome (classic presentation)
Headaches, nausea, vision changes, nystagmusCraniopharyngioma or other hypothalamic-pituitary tumour
Autonomic dysregulation, hypoventilationROHHAD/ROHHADNET syndrome

🔴 Domain 5: Physical and Genitourinary Findings

Red FlagSuspect
Dysmorphic features — unusual facies, small hands/feet, polydactylyBardet-Biedl syndrome (polydactyly), Prader-Willi syndrome, other chromosomal syndromes
Delayed or absent puberty, undescended testes, micropenis, small testesPrader-Willi syndrome, Bardet-Biedl syndrome, leptin deficiency, endocrine cause
Precocious pubertyCNS lesion, ROHHAD syndrome
Pale skin with red hair (in White individuals)POMC deficiency (classic triad: early-onset obesity + red hair + adrenal insufficiency)
Retinal pigmentation, visual impairment, or deafnessBardet-Biedl syndrome, Alström syndrome
Dry/coarse hair, constipation, cold intolerance, bradycardiaHypothyroidism
Violaceous striae, interscapular fat pad (buffalo hump), moon facies, proximal myopathy, hypertensionCushing syndrome / Cushing disease
Polydipsia, polyuriaDiabetes insipidus (hypothalamic cause), or new-onset T1DM masking with insulin-driven weight gain

Step 3 — Triage by Flag Pattern

Flags PresentMost Likely CauseUrgency
Onset < 2 yrs + severe hyperphagia, no dysmorphiaMonogenic obesity (leptin, POMC, MC4R)Elective referral to paediatric endocrinology/genetics
Neonatal hypotonia + later hyperphagia + developmental delay + hypogonadism + small hands/feetPrader-Willi syndromeGenetic testing (methylation studies) — confirm urgently
Polydactyly + retinal dystrophy + intellectual disability + hypogonadismBardet-Biedl syndromeGenetics + ophthalmology referral
Short stature + obesity + violaceous striae + buffalo humpCushing syndromeEndocrine workup (24h UFC, midnight salivary cortisol, low-dose DST)
Short stature + obesity + dry skin + constipation + bradycardiaHypothyroidismTSH + Free T4 — urgent
GH deficiency signs + short stature + obesityGH deficiencyIGF-1, IGFBP-3, GH stimulation testing
Rapid-onset obesity + autonomic dysfunction + hypoventilationROHHAD/ROHHADNETUrgent paediatric neurology/respirology
Headaches + visual changes + rapid weight gainCraniopharyngiomaUrgent MRI brain/pituitary
Red hair + early-onset obesity + adrenal insufficiency signsPOMC deficiencyUrgent cortisol, ACTH, genetics
Visual impairment + sensorineural deafness + obesityAlström syndromeGenetics + ophthalmology

Step 4 — Initial Investigations to Order

Based on red flags identified, order as indicated:

Endocrine screen (if short stature, striae, or growth deceleration):

  • TSH, Free T4
  • 24-hour urinary free cortisol or midnight salivary cortisol
  • Morning cortisol + ACTH
  • IGF-1, IGFBP-3

Genetic/syndromic workup:

  • Chromosomal microarray (for dysmorphic features or intellectual disability)
  • Prader-Willi methylation studies (if clinical features present)
  • Specific gene panel (leptin, leptin receptor, POMC, MC4R, BBS genes) via genetics referral

Neuroimaging:

  • MRI brain and pituitary (if headaches, visual symptoms, rapid-onset hypothalamic obesity, or ROHHAD suspected)

Ophthalmology:

  • Fundoscopy / ERG (if Bardet-Biedl or Alström suspected)

Clinical Guardrails

  • Short stature + obesity = endocrine cause until proven otherwise. Do not attribute growth failure to obesity alone.
  • POMC deficiency is rare but treatable — setmelanotide (MC4R agonist) is approved; early identification matters.
  • Leptin deficiency is also treatable with recombinant leptin — do not miss it in severe early-onset obesity.
  • Prader-Willi: Genetic confirmation should precede growth hormone therapy (standard of care in PWS); confirm before starting.
  • Cushing in children is almost always ACTH-dependent (Cushing disease) — screen carefully; obesity + hypertension + poor linear growth is the triad.
  • ROHHAD is life-threatening — hypoventilation can cause sudden death; refer urgently if suspected.
  • Monogenic obesity does not exclude pharmacotherapy — GLP-1RAs and setmelanotide may still be appropriate after diagnosis.

Source

Clinical content synthesised from:

  • CMAJ 2025 Clinical Practice Guideline: Managing obesity in children. Ball GDC et al. doi: 10.1503/cmaj.241456
  • Choquet H, Meyre D. Genetics of Obesity: What have we Learned? Curr Genomics. 2011.
  • Forsythe E, Beales PL. Bardet-Biedl Syndrome. Eur J Hum Genet. 2013.
  • Styne DM et al. Pediatric Obesity — Assessment, Treatment, and Prevention. JCEM 2017.

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题